Home › Mild Cognitive Impairment › Florida › Melbourne
Mild Cognitive Impairment clinical trials in Melbourne, FL
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Melbourne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Flutemetamol F 18 Injection Formulation Comparison
RecruitingPhase 2
- Meritt Island Research, LLC dba. Flourish Research, Merritt Island · 20 mi away
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Merritt Island Medical Research, LLC, Merritt Island · 20 mi away
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- Clincloud, LLC - Viera Office, Melbourne
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
RecruitingObservational studyHealthy volunteers welcome
- Clincloud, Melbourne
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY24 studies
- Boston, MA23 studies
- Chicago, IL16 studies
- Baltimore, MD14 studies
- Los Angeles, CA12 studies
- Miami, FL12 studies
- San Francisco, CA11 studies
- Atlanta, GA10 studies
- Houston, TX10 studies
- Birmingham, AL10 studies
- Philadelphia, PA10 studies
- Durham, NC9 studies
Other studies in Melbourne
- Alzheimer's Disease8 studies
- High Blood Pressure3 studies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy3 studies
- Chronic Kidney Disease3 studies
- Steatotic Liver Disease3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.